A Look At 5 IBD 50 Stocks With Upcoming Earnings

By | February 21, 2015

Scalper1 News

Five notable IBD 50 stocks are all set to issue their quarterly earnings in the coming week. United Therapeutics (UTHR) reports before the open on Tuesday. The cancer therapy developer’s stock is up 20% so far this year. Valeant Pharmaceuticals (VRX) also reports before the open on Tuesday. It could close its $160-a-share buyout deal with industry group peer Salix Pharmaceuticals (SLXP) soon. Valeant shares are up 21% in 2015. Apple (AAPL) chip Scalper1 News

Scalper1 News